1. Document de presse | 2022.07.22

    Meningref trial shows better protection against meningococcal infection in hematopoietic stem cell transplant recipients

    The team in the Hematology Department at Henri Mondor AP-HP Hospital, coordinated by Dr. Christine Robin, and scientists from the Institut Pasteur (the Invasive Bacterial Infections Unit led by Professor Muhamed-Kheir Taha) recently studied protection against meningococcal infection in patients who had received hematopoietic stem cell transplantation.The results of this trial (NCT03509051),...

  2. News | 2023.10.02

    Malaria: progress towards the use of monoclonal antibodies

    Although monoclonal antibodies seem to be a promising avenue for malaria prevention, their mechanism of action remains unclear. Scientists at the Institut Pasteur recently developed a model to study and identify more effective monoclonal antibodies.

  3. Document de presse | 2023.10.03

    The Institut Pasteur & the University of Tokyo have signed a LOI to establish the Planetary Health Innovation Center, marking the first step towards the Institut Pasteur of Japan

    At a ceremony in Tokyo on Tuesday October 3, 2023 attended by the French Ambassador to Japan, H.E. Philippe Setton, the President of the Institut Pasteur, Professor Stewart Cole, and the President and Rector of the University of Tokyo, Professor Teruo Fujii, signed a letter of intent (LOI) to establish the Planetary Health Innovation Center (PHIC), marking the first step towards the Institut...

  4. News | 2023.09.29

    Foodborne botulism: report on the recent outbreak

    In early September 2023, several people were infected after eating home-canned sardines in a bar in Bordeaux. By September 14, 2023, the outbreak had led to the death of one person, and 10 others had been admitted to hospital. Here is a detailed timeline of events and the Institut Pasteur's role in managing this health crisis. 

  5. News | 2023.04.25

    Malaria: improving blood filtration by the spleen to stop the disease transmission

    Malaria is a disease transmitted to humans by a mosquito bite, itself infected with a parasite. This parasite settles in the liver, then infects the red blood cells and destroys them. A Université Paris Cité - Inserm team, led by Prof. Pierre Buffet, Medical Vice-President of the Institut Pasteur, identifies two drugs likely to increase the efficiency of blood filtration by the spleen. This can...

  6. News | 2025.02.10

    The Institut Pasteur and AlterDiag announce the signature of a strategic partnership on research and development of next generation rapid diagnostic technologies

    Through this long-term strategic partnership agreement, the Institut Pasteur and AlterDiag will carry out research and development projects to develop new single-domain antibodies (VHH) -based rapid diagnostic tests using lateral flow immunochromatography, with the aim of strengthening the fight against infectious diseases. Scientific and technological collaboration to meet global health...

  7. News | 2025.05.30

    Institut Pasteur deploys MinoSuiteTM “Pioneer” platform from startup Minos Biosciences, developing next-generation cell analysis technology

    With the deployment of its MinoSuiteTM Pioneer platform at the Institut Pasteur, within the Dynamics of Host-Pathogen Interactions unit, headed by Dr. Jost Enninga, deep-tech startup Minos Biosciences has officially launched its Early Access Program. The strategic collaboration between Minos Biosciences and the teams of Jost ENNINGA and Milena HASAN from the Institut Pasteur, partially funded by...

  8. Article | 2025.07.09

    Virology

    Fighting viral infections that affect human health.

  9. News | 2019.06.04

    At the Institut Pasteur, a new insectarium for arbovirus mosquito vectors

    The Institut Pasteur in Paris has opened a vast new insectarium for rearing mosquitoes with the potential to transmit arboviruses – viruses transmitted between vertebrates via a bite from a hematophagous vector. By rearing large quantities of mosquitoes in controlled conditions at this new facility, scientists will be better equipped to tackle future challenges associated with emerging vector-...

  10. News | 2026.04.02

    Institut Pasteur and L'Oréal announce an ambitious partnership to Decode Skin Health

    The Institut Pasteur is pleased to announce a landmark research partnership with L'Oréal, the world's leading beauty company, marking the first scientific agreement of its kind between these two world-renowned French institutions.This strategic alliance brings together complementary expertise in immunology, microbiology, and beauty science to investigate the skin as a complex living ecosystem....

Pages

Back to top